Media
News
SRF: Schweizer Start-up zieht bei Antikörpertests mit Roche gleich

Corona Antikörpertests rücken immer mehr in den Vordergrund. Gross in diesem Geschäft ist der Basler Pharma-Multi Roche. Neu auf dem Markt behauptet sich das Waadtländer Start-up Quotient.

STV: What does getting a coronavirus antibody test involve?

On the 8th of June, reporter Gordon Chree from STV visited Quotient's Allan-Robb Campus in Penicuik, Scotland to interview Quotient Chief Operating Officer. While on site, he was also tested using the MosaiQ COVID-19 Antibody Microarray

The Sun: I took the antibody test that could help get millions back to work – by revealing they’ve had COVID WITHOUT realising

On the 6th of June 2020, The Sun journalist Alex Bellotti visited an hVIVO laboratory in East London to try out the newly launched “gold standard” coronavirus antibody test provided by Quotient using their MosaiQ technology.

Handelzeitung: Ein Ehemaliger will es wissen

Quotient Das Startup bringt den ersten in der Schweiz  produzierten Antikörpertest  auf den Markt. Dahinter steckt ein Ex-Roche-Manager.

Quotient Limited and hVIVO Announce Partnership to Support Wide-Spread COVID-19 Antibody Testing in the UK

JERSEY, Channel Islands, May 11, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, headquartered in Eysins, Switzerland, and hVIVO, part of Open Orphan plc (LONDON:ORPH), today announced that the MosaiQ™ by Quotient system and MosaiQ

Quotient CEO Franz Walt on talkRADIO with Mike Graham

Quotient CEO Franz Walt was interviewed on 05 May 2020 by Mike Graham on talkRADIO. They discussed the recently CE marked MosaiQ COVID-19 Antibody microarray, antibody testing, and the global COVID-19 pandemic. 

 

Quotient Limited Announces CE Mark for its SARS-CoV-2 (COVID-19) Antibody Microarray

JERSEY, Channel Islands, 1 May, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced that it has completed the process for declaring conformity to the essential requirements of the In V

Quotient Limited Announces SARS-CoV-2 (COVID-19) Antibody Test Final Performance Data

JERSEY, Channel Islands, April 27, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today reported very strong final study performance data for its SARS-CoV-2 antibody test.

Quotient Limited Announces SARS-CoV-2 (COVID-19) Antibody Test Performance Update

JERSEY, Channel Islands, April 21, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today reported positive performance data for its SARS-CoV-2 antibody test.

The Times UK: Antibody tests and 'mass diagnosis'

Mass diagnosis ‘available now’